Clinical Trials Logo

Dandruff clinical trials

View clinical trials related to Dandruff.

Filter by:

NCT ID: NCT06436495 Completed - Dandruff Clinical Trials

Methodology Validation: Correlating Adherent Scalp Flaking Score (ASFS) With Phototrichogram for Scalp Dandruff Evaluation in Adult Subjects

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

This study aims to validate methods for assessing scalp hair dandruff by comparing three evaluation techniques: the Adherent Scalp Flaking Score (ASFS), Phototrichogram, and 60-second hair combing. These assessments will be conducted before and after hair wash interventions on adult human subjects to evaluate adherent and non-adherent scalp flakes. By comparing the results of these evaluations, the study aims to determine the consistency and reliability of each method in assessing the presence and severity of dandruff. Establishing correlation between these assessment techniques is essential for validating their usefulness in evaluating the effectiveness of hair care products and treatments in reducing scalp dandruff. This research aims to improve the accuracy and reliability of dandruff evaluation methods, benefiting both dermatological research and clinical practice in managing this prevalent condition.

NCT ID: NCT06052241 Completed - Folliculitis Clinical Trials

Artificial Intelligence-based Prescription of Personalized Scalp Cosmetics

Start date: July 27, 2021
Phase: N/A
Study type: Interventional

The investigators aimed to evaluate whether they can be improved by an AI-based personalized prescription of scalp cosmetics.

NCT ID: NCT05989633 Completed - Dandruff Clinical Trials

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

Start date: July 4, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS

NCT ID: NCT05506592 Not yet recruiting - Dandruff Clinical Trials

Evaluation of the Efficacy of SeS2 Shampoo on Subjects Having Dandruff

Start date: October 2022
Phase: N/A
Study type: Interventional

A shampoo containing SeS2 was evaluated versus placebo on healthy subjects suffering from dandruff in order to assess clinical benefits and its impact on fungal and bacterial scalp microbiota.

NCT ID: NCT05503706 Not yet recruiting - Dandruff Clinical Trials

Effects on the Scalp Lipids and TEWL of a 1% Selenium Disulfide and 1% Salicylic Acid Antidandruff Shampoo on Dandruff Scalp

Start date: September 2022
Phase: N/A
Study type: Interventional

The aim of this study was to investigate the changes in the scalp lipids and TEWL in dandruff subjects treated by 1% Selenium Disulfide (SeS2)/1% salicylic acid-based shampoo after an antidandruff treatment and after a remanence phase

NCT ID: NCT05319444 Recruiting - Hair Loss Clinical Trials

Cleansing Device for the Treatment of Scalp and Hair Conditions

Start date: June 30, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate an improvement of scalp health after the use of an investigational off-label WaterPik and brush device aimed to massage and cleanse the scalp.

NCT ID: NCT03834935 Not yet recruiting - Pityriasis Alba Clinical Trials

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

Start date: March 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Pityriasis alba (PA) is a common benign skin disorder, that usually affects children and adolescents of darker phototypes. A history of atopic dermatitis is a well-known risk factor, and PA may be a minor manifestation of atopic dermatitis, although it can occur in nonatopic individuals as well. The objective is to evaluate the effect of topical pimecrolimus in the treatment of treatment of PA

NCT ID: NCT03443765 Active, not recruiting - Pityriasis Alba Clinical Trials

Serum 25(OH) Vitamin D and Total Serum Immunoglobulin E Levels in Patients With Pityriasis Alba

Start date: May 1, 2017
Phase:
Study type: Observational [Patient Registry]

Pityriasis alba (PA) is a common, benign skin disorder occurring predominantly in children and adolescents. It is characterized by ill-defined hypopigmented macules and patches, round or oval in shape. They are most commonly located on the face (especially the cheeks), arms, and upper trunk; and they are more noticeable in people with darker skin types. Sun exposure accentuates the lesions. Patients and their parents are often anxious about the cosmetic appearance of the lesions. PA is not seasonal, although peeling may be worse in the winter (as a result of dry air in homes) and lesions may be more obvious in the spring and summer (as a result of sun exposure and darkening of the surrounding skin).No specific cause of PA has been identified. It is not contagious, and no infectious etiology has been reported. It is most common in individuals with a history of atopy, although it may occur in nonatopic individuals. In the present study, we will investigate the role of serum vitamin D levels and serum total IgE levels with development and course of PA. Plasma levels of 25(OH) vitamin D and Total serum immunoglobulin E will be determined by using ELISA technique.

NCT ID: NCT02448082 Completed - Dandruff Clinical Trials

The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis

Start date: October 2014
Phase: Phase 2
Study type: Interventional

Dandruff, also known as Pityriasis capitis, is a common condition which affects the scalp of almost half the post-pubertal population regardless of race and gender. It is said that dandruff affects at least 50% of the world's adult population and about 15 - 20% of the world's total population. Dandruff is usually marked by flaking as well as itching and irritation of the scalp which can also lead to greasiness. Dandruff can lead to physiological and psychological issues and can be very distressing and embarrassing for the sufferer, causing low self esteem and social problems. Current treatment options for dandruff include many over-the-counter preparations, anti-dandruff shampoos and topical steroid applications which are accompanied by numerous adverse effects. According to Lunar Pharmaceuticals Ichthyol® Pale is a sodium salt of pale sulphonated shale oil in aqueous solution with anti-microbial properties which can combat dandruff helping with the causative and symptomatic relief of this condition. The aim of the study is to determine the efficacy of Sodium Shale Oil Sulponate 1% shampoo in the treatment of Pityriasis capitis. This will be evaluated using the Adherent Scalp Flaking Score (ASFS) grading and the Visual Analogue Scale (VAS).

NCT ID: NCT01388517 Completed - Pityriasis Alba Clinical Trials

Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba

Start date: January 2008
Phase: Phase 4
Study type: Interventional

Pityriasis alba (PA) is a frequent cause of consultation in tropical areas due to its chronic course, trend to relapse and aesthetic impact. Currently, no treatment is widely accepted. The objective is to assess the calcitriol and tacrolimus ointment efficacy in the treatment of PA compared with petrolatum. Twenty lesions on the face greater than 3 cm, in individuals of phototype IV-V, aged 3-18 years are going to be randomly assigned to receive petrolatum, calcitriol, and tacrolimus twice daily. No photoprotection is going to be indicated, and hygienic habits will not be modified. Patients will be evaluated at baseline and for 9 weeks, by means of Transepidermal Water Loss (TEWL), colorimetry, clinically and by photography control.